![]()
|
Report Date : |
21.06.2011 |
IDENTIFICATION DETAILS
|
Name : |
BAYER MATERIALSCIENCE PRIVATE LIMITED |
|
|
|
|
Registered Office : |
Bayer House, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2010 |
|
|
|
|
Date of Incorporation : |
11.09.1995 |
|
|
|
|
Com. Reg. No.: |
179724 |
|
|
|
|
Capital Investment / Paid-up Capital : |
Rs.1002.677 millions |
|
|
|
|
CIN No.: [Company
Identification No.] |
u19113mh1995ptc179724 |
|
|
|
|
Legal Form : |
Private Limited Liability Company
|
|
|
|
|
Line of Business : |
Manufacturer of Thermoplastic Polyurethanes and Chemicals |
|
|
|
|
No. of Employees : |
200 (In office) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 4610984 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a subsidiary of Bayer AG, It is a well established and reputed company having satisfactory
track. Trade relations are reported as fair. business is active. Payments are reported to be usually
correct and as per commitments. In view of strong Holding Company the subject can be considered normal
for business dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
INFORMATION PARTED BY (GENERAL DETAILS)
|
Name : |
Mr. Hasmukh Patel |
|
Designation : |
Accounts Manager |
|
Date : |
21.06.2011 |
LOCATIONS
|
Registered Office : |
Bayer House, |
|
Tel. No.: |
91-22-25711234 |
|
Fax No.: |
91-22-25700147 |
|
E-Mail : |
niranjan.ketkar@bayercropscience.com |
|
Website : |
|
|
Area : |
2500Sq.ft. |
|
Location : |
Owned |
|
|
|
|
Factory : |
Located at: · Noida, Grater Noida · Ankleshwar, GIDC ·
Cuddalore, Chennai |
DIRECTORS
AS ON 17.08.2010
|
Name : |
Mr. Stephan Feirdhelm Gerlich |
|
Designation : |
Chairman Cum Managing Director |
|
Address : |
Vinrita, Flat No. 13 and 14, Plot No. 98 of TPS IV, Prof. Almedia
Road, Bandra, Mumbai – 400 050 |
|
Date of Birth/Age : |
11.09.1958 |
|
Date of Appointment : |
24.07.2008 |
|
|
|
|
Name : |
Mr. Kaikobad Behram Mistry |
|
Designation : |
Director |
|
Address : |
The |
|
Date of Birth/Age : |
16.12.1959 |
|
Date of Appointment : |
01.07.2008 |
|
|
|
|
Name : |
Mr. Darius Cavasji Shroff |
|
Designation : |
Director |
|
Address : |
Moonlight, Flat No. 8, |
|
Date of Birth/Age : |
08.08.1944 |
|
Date of Appointment : |
07.12.2006 |
|
|
|
|
Name : |
Mr. Subrahmanian Kugalur Ramasesha Venkata |
|
Designation : |
Director |
|
Address : |
8, Rushilla, 17C, |
|
Date of Birth/Age : |
26.09.1933 |
|
Date of Appointment : |
13.06.1996 |
KEY EXECUTIVES
|
Name : |
Mr. Niranajn Arun Ketkar |
|
Designation : |
Secretary |
|
Address : |
A/101, Om |
|
Date of Birth/Age : |
27.09.1975 |
|
Date of Appointment : |
26.02.2007 |
|
|
|
|
Name : |
Mr. Hasmukh Patel |
|
Designation : |
Account Manager |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 17.08.2010
|
Names of Shareholders |
|
No. of Shares |
|
Bayer AG, |
|
100267652 |
|
Bayer AG jointly with Shirin V Balsara, |
|
1 |
|
Bayer AG jointly with |
|
1 |
|
Total |
|
100267654 |
AS ON : 30.09.2010
|
Equity Share
Breakup |
|
Percentage of
Holding |
|
Category |
|
|
|
Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others] |
|
100.00 |
|
|
|
|
|
|
Total
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Thermoplastic Polyurethanes and Chemicals |
||||||||
|
|
|
||||||||
|
Products : |
|
||||||||
|
|
|
||||||||
|
|
|
||||||||
|
Exports : |
|
||||||||
|
Products : |
Thermoplastic Polyurethanes |
||||||||
|
Countries : |
·
China ·
Germany |
||||||||
|
|
|
||||||||
|
Imports : |
|
||||||||
|
Products : |
Raw Material |
||||||||
|
Countries : |
·
China ·
Thailand |
||||||||
|
|
|
||||||||
|
Terms : |
|
||||||||
|
Selling : |
Cash, Credit (30 days / 60
days) |
||||||||
|
|
|
||||||||
|
Purchasing : |
Cash, Credit (30 days / 60
days) |
GENERAL INFORMATION
|
Customers : |
|
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
No. of Employees : |
200 (In office) |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Bankers : |
HDFC Bank, Senapati Bapat Marg, Lower Parel, Mumbai, Maharashtra,
India |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Facilities : |
Notes: Of the above, due within one year Rs. 437.225 millions (Previous
Period Rs. 1027.997 millions) |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Banking
Relations : |
--- |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Auditors : |
|
|||||||||||||||||||||
|
Name : |
Price Waterhouse Chartered Accountants |
|||||||||||||||||||||
|
Address : |
252, Veer Savarkar Marg, |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Holding Company : |
Bayer AG |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Subsidiaries : |
·
Bayer Pharmaceuticals Private Limited, · Bayer Cropscience Limited · Bayer Bioscience Private Limited |
CAPITAL STRUCTURE
As on: 31.03.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
160000000 |
Equity Shares |
Rs. 10/- each |
Rs. 1600.000 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
100267654 |
Equity Shares |
Rs. 10/- each |
Rs.1002.677
millions |
Note :
100,267,654
(Previous year 100,267,654) Equity shares are held by Byer AG,
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
1002.676 |
1002.676 |
1002.677 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
150.070 |
136.298 |
297.202 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
1152.746 |
1138.974 |
1299.879 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
2313.225 |
1139.997 |
533.158 |
|
|
TOTAL BORROWING |
2313.225 |
1139.997 |
533.158 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3465.971 |
2278.971 |
1833.037 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
595.687 |
601.687 |
599.529 |
|
|
Capital work-in-progress |
1276.350 |
246.284 |
5.593 |
|
|
|
|
|
|
|
|
INVESTMENT |
89.528 |
218.666 |
243.666 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
5.075 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
693.255 |
438.414 |
559.126 |
|
|
Sundry Debtors |
709.000
|
642.846 |
432.917 |
|
|
Cash & Bank Balances |
478.942
|
34.570 |
19.312 |
|
|
Other Current Assets |
0.000 |
0.000 |
0.000 |
|
|
Loans & Advances |
408.345
|
476.827 |
411.299 |
|
Total
Current Assets |
2289.542
|
1592.657 |
1422.654 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
58.407
|
18.076 |
19.068 |
|
|
Sundry Creditors |
683.441
|
349.343 |
414.713 |
|
|
Provisions |
43.288
|
12.905 |
9.699 |
|
Total
Current Liabilities |
785.136
|
380.324 |
443.480 |
|
|
Net Current Assets |
1504.406
|
1212.334 |
979.174 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3465.971 |
2278.971 |
1833.037 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
|
2976.292 |
|
|
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL (A) |
2976.292 |
2047.164 |
2094.239 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Manufacturing Expenses |
|
|
|
|
|
|
Employees Remuneration |
|
|
|
|
|
|
Increase/(Decrease) in Finished Goods |
2924.448 |
2209.542 |
2018.339 |
|
|
|
Selling and Distribution Expenses |
|
|
|
|
|
|
Office Expenses |
|
|
|
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL (B) |
2924.448 |
2209.542 |
2018.339 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
51.844 |
(162.378) |
75.900 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
51.844 |
(162.378) |
75.900 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
51.844 |
(162.378) |
75.900 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
38.074 |
(1.477) |
47.813 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
13.770 |
(160.901) |
28.087 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Export Earnings |
|
72.062 |
132.922 |
|
|
|
Commission Earnings |
2104.000 |
286.947 |
325.900 |
|
|
|
Other Earnings |
|
0.000 |
10.747 |
|
|
TOTAL EARNINGS |
2104.000 |
359.009 |
469.569 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
NA |
545.912 |
422.363 |
|
|
|
Stores & Spares |
NA |
2.087 |
3.609 |
|
|
|
Capital Goods |
NA |
140.073 |
52.634 |
|
|
|
Others |
NA |
495.252 |
995.081 |
|
|
TOTAL IMPORTS |
NA |
1183.324 |
1473.687 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
0.14 |
1.60 |
0.28 |
|
Expected Sales (2010 - 2011) : Rs. 3500.000 millions (Expected)
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
0.46
|
(7.86) |
1.34 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
1.74 |
(7.93) |
3.62 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
1.80
|
(7.40) |
3.75 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.04
|
(0.14) |
0.06 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
2.69
|
1.33 |
0.75 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.92
|
4.19 |
3.21 |
LOCAL AGENCY FURTHER INFORMATION
SUNDRY CREDITORS
|
Particulars |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
Due to Micro and Small Enterprises |
0.001 |
0.000 |
0.000 |
|
Due to Others |
683.145 |
349.048 |
414.405 |
|
Deposits from Agents and Dealers |
0.295 |
0.295 |
0.295 |
|
Due to Subsidiary Company |
0.000 |
0.000 |
0.013 |
|
Total |
683.441 |
349.343 |
414.713 |
Operations:
During the year under review, the Company has earned a total income
including other income of Rs. 2976.000 millions (previous year Rs. 2047.000
million) which includes Rs. 339.000 millions (previous year Rs. 359.000 millions)
by way of exports. After meeting the operative expenses, the profit before tax
works out to Rs. 52.000 millions (previous year loss before tax Rs. 162.000
millions).
TRADE
REFERANCE :
Baxter Healthcare Limited
Atlas Weighing Equipments,
Material
Developments:
The Scheme of Amalgamation of subsidiary companies of the Company viz.,
Bayer Polychem (India) Limited with Bayer Pharmaceuticals Private Limited was
approved by the Hong Kong’ble High Court of Bombay on 27th November,
2009. Pursuant to the said sceme Bayer Polychem (
Bayer Pharmaceuticals Private Limited (BPPL) was 100% subsidiary of the Company.
The Company vide its board resolution dated 5th December, 2009
approved the sale of entire equity share capital of BPPL in favour of Bayer (
Hence, as on 31st March, 2010 the Company does not have any
subsidiary.
change of address:
the Registered Address of the company was 1-2, Community Centre, Aram Bagh, panchkuian Road, New Delhi – 110 055 change to present Registered Office w.e.f 15.02.2008.
TRADE REFERENCES:
· Moserbaer India Limited
· Siemens India
FIXED ASSETS :
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.99 |
|
|
1 |
Rs.72.59 |
|
Euro |
1 |
Rs.64.01 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
no |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
no |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
no |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
no |
|
--OTHER MERIT FACTORS |
YES/NO |
yes |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.